Bin Xu Selected Research

Bin Xu Research Topics

Disease

288	Neoplasms (Cancer) 11/2022 - 11/2002
66	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2002
61	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 06/2009
51	Infections 08/2022 - 06/2003
41	Carcinoma (Carcinomatosis) 01/2022 - 01/2003
32	Inflammation (Inflammations) 08/2022 - 01/2013
30	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2002
29	Breast Neoplasms (Breast Cancer) 06/2022 - 10/2006
27	Carcinogenesis 01/2022 - 01/2011
26	Obesity 10/2021 - 05/2005
24	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2010
21	Wounds and Injuries (Trauma) 08/2022 - 01/2014
21	Pain (Aches) 01/2022 - 06/2008
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2014
19	Body Weight (Weight, Body) 05/2021 - 01/2010
18	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 11/2009
18	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2006
18	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 12/2015
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2010
16	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2011
13	Fibrosis (Cirrhosis) 08/2022 - 04/2002
13	Hemorrhage 04/2022 - 03/2003
13	COVID-19 10/2021 - 01/2020
13	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2012
12	Melanoma (Melanoma, Malignant) 06/2022 - 04/2011
12	Glioma (Gliomas) 04/2022 - 10/2014
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2009
11	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2014
11	Stroke (Strokes) 03/2022 - 11/2015
11	Adenocarcinoma of Lung 01/2021 - 11/2011
11	Disease Progression 01/2021 - 06/2008
10	Insulin Resistance 01/2022 - 07/2009
10	Ischemia 05/2021 - 10/2003
10	Schizophrenia (Dementia Praecox) 12/2019 - 10/2005
9	Hypertension (High Blood Pressure) 08/2022 - 01/2016
9	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 06/2012
9	Diabetes Mellitus 02/2021 - 07/2004
9	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2013
9	Adenocarcinoma 01/2021 - 03/2009
8	Heart Failure 03/2022 - 12/2014
8	Atrial Fibrillation 12/2021 - 09/2011
8	Acquired Immunodeficiency Syndrome (AIDS) 11/2021 - 02/2010
8	Colonic Neoplasms (Colon Cancer) 02/2021 - 05/2013
8	Hypoxia (Hypoxemia) 02/2021 - 10/2008
8	Poisoning 11/2020 - 10/2013
8	Constipation 08/2020 - 03/2014

Drug/Important Bio-Agent (IBA)

106	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2002
62	Biomarkers (Surrogate Marker)IBA 03/2022 - 10/2009
45	MicroRNAs (MicroRNA)IBA 05/2022 - 04/2010
43	Biological ProductsIBA 04/2022 - 04/2005
38	Messenger RNA (mRNA)IBA 06/2022 - 11/2002
31	CytokinesIBA 12/2021 - 04/2002
30	Therapeutic UsesIBA 11/2022 - 02/2004
25	Pharmaceutical PreparationsIBA 03/2022 - 12/2004
25	Long Noncoding RNAIBA 03/2022 - 09/2016
24	RNA (Ribonucleic Acid)IBA 06/2022 - 10/2005
22	AntigensIBA 01/2021 - 06/2009
16	VaccinesIBA 08/2022 - 01/2006
15	Peptides (Polypeptides)IBA 08/2022 - 01/2014
15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2009
15	AndrogensIBA 01/2020 - 06/2009
14	Circular RNAIBA 11/2022 - 01/2019
14	CholesterolIBA 03/2022 - 06/2011
14	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2011
14	EnzymesIBA 01/2021 - 07/2010
13	Transcription Factors (Transcription Factor)IBA 04/2022 - 04/2011
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 02/2004
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2006
11	LipidsIBA 09/2021 - 07/2008
11	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
11	Insulin (Novolin)FDA Link 01/2018 - 06/2004
10	Blood Glucose (Blood Sugar)IBA 03/2022 - 07/2009
10	ManganeseIBA 02/2022 - 12/2016
10	Phosphotransferases (Kinase)IBA 01/2021 - 03/2009
10	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2014
9	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 07/2006
9	Lysine (L-Lysine)FDA Link 01/2022 - 04/2011
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2009
9	InterleukinsIBA 07/2020 - 04/2003
9	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2014
8	Competitive Endogenous RNAIBA 01/2022 - 01/2016
8	C-Reactive ProteinIBA 12/2021 - 01/2018
8	Interleukin-10 (Interleukin 10)IBA 11/2020 - 04/2003
8	oxidized low density lipoproteinIBA 05/2020 - 01/2014
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2003
7	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2018

Therapy/Procedure

106	Therapeutics 06/2022 - 05/2008
37	Drug Therapy (Chemotherapy) 01/2022 - 05/2006
20	Electroacupuncture 03/2022 - 05/2005
20	Immunotherapy 01/2022 - 01/2014
18	Aftercare (After-Treatment) 11/2021 - 12/2008
16	Length of Stay 01/2022 - 12/2012
16	Radiotherapy 01/2022 - 01/2003
15	Castration 01/2022 - 08/2012
11	Nephrectomy 01/2022 - 01/2015
11	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2010
10	Hepatectomy 06/2022 - 01/2004
10	Lasers (Laser) 01/2022 - 09/2012
8	Operative Time 01/2022 - 02/2014
8	Acupuncture Points (Acupuncture Point) 11/2021 - 12/2010